Cargando…
A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
Delivery technologies for the CRISPR-Cas9 gene editing system often require viral vectors, which pose safety concerns for therapeutic genome editing(1). Alternatively, cationic liposomal components or polymers can be used to encapsulate multiple CRISPR components into large particles (typically >...
Autores principales: | Chen, Guojun, Abdeen, Amr A., Wang, Yuyuan, Shahi, Pawan K., Robertson, Samantha, Xie, Ruosen, Suzuki, Masatoshi, Pattnaik, Bikash R., Saha, Krishanu, Gong, Shaoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778035/ https://www.ncbi.nlm.nih.gov/pubmed/31501532 http://dx.doi.org/10.1038/s41565-019-0539-2 |
Ejemplares similares
-
Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing
por: Carlson-Stevermer, Jared, et al.
Publicado: (2017) -
Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy
por: Kabra, Meha, et al.
Publicado: (2023) -
Non-viral approaches for gene therapy and therapeutic genome editing across the blood–brain barrier
por: Xie, Ruosen, et al.
Publicado: (2023) -
Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing
por: Whitley, Joseph Andrew, et al.
Publicado: (2023) -
PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts
por: Sant’Ana, Rodrigo Ribeiro Arnt, et al.
Publicado: (2020)